In human colorectal cancer, the expression of CCL2 increases with cancer progression, and CCL2 deficiency has been associated with reduced infiltration of intratumoral MDSCs and smaller tumor sizes in spontaneous mouse models of colon cancer [388]. Here, CCL2 is linked to malignant colon neoplasm.